Hemoglobin level as a cardiovascular risk factor in nafld

Abstract

Nonalcoholic fatty liver disease (NAFLD) is currently the most common form of chronic liver disease. Identification of novel risk factors for NAFLD has practical implications for the selection of cases for histologic assessment of disease severity and progression in the presence of abnormal liver enzymes, as well as the opening of new treatment avenues. Hemoglobin concentrations were the chief predictor of both NASH and severe fibrosis in NAFLD, but in other contest could affect the cardiovascular system through oxygen supply and blood viscosity. The relation Hemoglobine - NAFLD – Cardiovascular Disease may open a new perspective in management of NAFLD and could lead to the development of novel therapeutic avenues in treatment of this chronic liver disorder.